Johnson & Johnson exec signs on for Algorae AI drug development 0 28.11.2024 07:45 Sydney Morning Herald Johnson & Johnson exec Dr Sarah Siggins has signed on for ASX-listed Algorae Pharmaceuticals’ hunt to create drug combinations recommended by AI to tackle hard to beat diseases. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
